Navigation Links
Genzyme and Bayer Schering Pharma AG, Germany to Present New Data on Alemtuzumab in Multiple Sclerosis at ECTRIMS
Date:10/11/2007

immune system can attack the brain and spinal cord. The disease causes a wide range of symptoms including fatigue, difficulty walking, numbness, and vision problems, and can progress to cause severe disability. Relapsing-remitting MS is the most common form of this disease.

According to the National Multiple Sclerosis Society, approximately 400,000 Americans acknowledge having MS, and every week about 200 people are diagnosed. Worldwide, multiple sclerosis may affect 2.5 million individuals.

About Alemtuzumab

Alemtuzumab is licensed in the United States as a single agent for the treatment of B-cell chronic lymphocytic leukemia (B-CLL), and outside of the U.S. for the treatment of B-CLL in patients who have been treated with alkylating agents and who have failed fludarabine therapy. The product was launched in its oncology indication in 2001 in the US, where it is marketed by Bayer HealthCare Pharmaceuticals Inc. as Campath(R), and in Europe, where it is named MabCampath(R).

Alemtuzumab is a humanized monoclonal antibody that binds to a specific target, CD52, on cell surfaces and directs the body's immune system to destroy those cells. It is the first and only monoclonal antibody approved by the FDA for the treatment of patients with B-CLL.

Campath has a boxed warning which includes information on cytopenias, infusion reactions, and infections. The most commonly reported adverse reactions in patients with B-CLL were infusion reactions (fever, chills, hypotension, urticaria, nausea, rash, tachycardia, dyspnea), cytopenias (neutropenia, lymphopenia, thrombocytopenia, anemia), and infections (CMV viremia, CMV infection, other infections). In clinical trials, the frequency of infusion reactions was highest in the first week of treatment. Other commonly reported adverse reactions include vomiting, abdominal pain, insomnia and anxiety. The most commonly reported serious adverse reactions are cytopenias, infusion reactions, and immunosuppressio
'/>"/>

SOURCE Genzyme
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Genzyme Announces First Phase III Study of Tolevamer in Diarrhea Patients
2. Bayer Voluntarily Withdraws BAYCOL - A Drug Associated With 50 Deaths
3. Bayer Wins Positive Response For Marketing Its Cancer Drug
4. Genomatix Licensed By Bayer Healthcare
5. Bayer to Market Biocon Insulin in China
6. Test for Esophageal Reflux Licensed to Bayer by University
7. Bayer and Onyx Submit Supplemental New Drug Application for Nexavar to Treat Liver Cancer
8. Dow Acquires Wolff Walsrode from Bayer
9. Asmanex Twisthaler launched by Schering-Plough for treatment of asthma
10. India to benefit from pharma companies move
11. South Africa Wins landmark case against pharmaceutical giants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... at the Universities of Manchester and Auckland suggest that both ... mechanism. , The findings, published today in the ... or type-1 diabetes and type-2 diabetes are both caused by ... , The results, based on 20 years, work ... both be slowed down and potentially reversed by medicines that ...
(Date:8/20/2014)... VA (PRWEB) August 20, 2014 ... nation’s leading nonprofit authority on the use of ... exchange, announced the full agenda for its annual ... Health IT Efficiency. WEDI-Con 2014 will take place ... October 20-23, 2014, attracting a diverse cross-section of ...
(Date:8/20/2014)... The National Association of Hispanic ... Science Education Partnership Award (SEPA) grant from the ... project with the Hispanic Communications Network (HCN) entitled ... collaborative NIH R25 program has been established to ... among health professionals by recruiting and interviewing bilingual ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Attendees of ... a sneak peak at Los Angeles’ first multi-faceted food ... tour of a blossoming 1.5-acre high school campus urban ... shipping container farm in the L.A. Art District. , ... of sustainable urban agriculture, will kick off Seedstock’s “Reintegrating ...
(Date:8/20/2014)... Charlotte, North Carolina (PRWEB) August 20, 2014 ... BBC , findings from a University College London (UCL) ... drastically disagreed on what method of brushing teeth was ... worldwide found that six different tooth-brushing techniques were frequently ... At the Charlotte Center for Cosmetic Dentistry, experienced ...
Breaking Medicine News(10 mins):Health News:Scientists show type-1 and type-2 diabetes are caused by same underlying mechanism 2Health News:WEDI Releases Full Conference Agenda for Its Annual Fall Conference – WEDI-Con 2014 2Health News:WEDI Releases Full Conference Agenda for Its Annual Fall Conference – WEDI-Con 2014 3Health News:National Association of Hispanic Nurses (NAHN) Receives Five-Year Federal Grant from the National Institutes of Health (NIH) 2Health News:National Association of Hispanic Nurses (NAHN) Receives Five-Year Federal Grant from the National Institutes of Health (NIH) 3Health News:Seedstock Sustainable Agriculture Conference’s Urban Farm Field Trip to Offer First Look at Los Angeles’ Premier Food Business Incubator 2Health News:Seedstock Sustainable Agriculture Conference’s Urban Farm Field Trip to Offer First Look at Los Angeles’ Premier Food Business Incubator 3Health News:Ending Confusion About the Best Way to Brush Teeth 2Health News:Ending Confusion About the Best Way to Brush Teeth 3
... , RANCHO SANTA FE, Calif., Dec. 22 ... Helen Woodward Animal Center (HWAC) began a quest to change the ... Animal Sanctuary the HWAC team from Rancho Santa Fe, CA learned ... Society facility on the island only three of the 120 dogs ...
... ... a comprehensive New Jersey anti-poverty charity, seeks year-end charitable contributions to meet an increasing need. ... Paterson, NJ (PRWEB) December ... Jersey during the current economic recession. By giving a charitable contribution to this trustworthy ...
... Ecumen applies hospitality ... ... development expert for Ecumen , Julie Murray spent the better part of her ... the Caribbean. , , ,Murray sees multiple parallels between providing hospitality in the expanding ...
... in the January issue of Radiology , 42 percent ... to undergo the procedure. "Given that MRI is ... cancer, we were surprised that barely half of women at ... offered at no cost," said Wendie A. Berg, M.D., Ph.D., ...
... , ANNAPOLIS, Md., Dec. 21 SCLogic, ... today announced the donation of its SCL Intra (TM) package ... a donation of a Motorola MC55 Enterprise Digital Assistant (EDA). ... in Florida designed for children with life-threatening illnesses, will use ...
... , , , , CHARLOTTE, N.C., Dec. 21 ... announced today it is investing in industry-leading technology in both ... marketplace. , (Logo: http://www.newscom.com/cgi-bin/prnh/20080903/CLW036LOGO-b ) , ... the U.S. and China. Construction associated with the projects is ...
Cached Medicine News:Health News:While Some Were Counting Sugar Plums...Others Were Changing the Future 2Health News:Eva's Village, a Paterson, New Jersey Anti-Poverty Charity, Seeks End of Year Charitable Contributions to Help Poor in a Troubled Economy 2Health News:Eva's Village, a Paterson, New Jersey Anti-Poverty Charity, Seeks End of Year Charitable Contributions to Help Poor in a Troubled Economy 3Health News:Ecumen Provides 10 Tips to Make Senior Housing a Cruise Ship on Land 2Health News:Ecumen Provides 10 Tips to Make Senior Housing a Cruise Ship on Land 3Health News:Ecumen Provides 10 Tips to Make Senior Housing a Cruise Ship on Land 4Health News:Elevated-risk women refuse MRI breast cancer screening 2Health News:SCLogic Donates Mobile Enterprise Tracking Solution to Give Kids The World Village 2Health News:PGI To Invest in Nonwovens Technology in U.S. and Asia to Serve Hygiene and Healthcare Markets 2Health News:PGI To Invest in Nonwovens Technology in U.S. and Asia to Serve Hygiene and Healthcare Markets 3
(Date:8/19/2014)... Aug. 19, 2014 Research and Markets ... Type of Material, by Technology, by Application & by Region- ... offering. The demand for membranes is estimated ... the market to $29.31 billion Membrane technology was ... such as water filtration and kidney dialysis. In modern times, ...
(Date:8/19/2014)... , Aug. 19, 2014 Avizia, Inc., ... that it has closed an equity financing round led ... Middleland Capital. The new funding will be used to ... this financing round, Avizia welcomes Edward Kennedy , ... of directors. He joins Leonard Kurtzman , CFO ...
(Date:8/19/2014)... Calif. , Aug. 19, 2014  Cardiva Medical, ... two tranches of a $16.5 million Series 3 private ... with GE Capital. The Company will use the proceeds ... facility to expand commercial efforts for its VASCADE® Vascular ... . Investing in Series 3 private ...
Breaking Medicine Technology:Global Membranes (MF, RO, UF, Gas Separation, Dialysis, NF) Market - Forecasts to 2019 2Avizia Closes Funding Round 2Cardiva Medical, Inc. Announces Completion of the first two tranches of Series 3 Private Equity Financing and the Closing of a Senior Secured Debt Facility with GE Capital 2
... Inhibitex, Inc. (Nasdaq: INHX ) today announced that ... its common stock, at a purchase price of $4.10 per ... proceeds to Inhibitex from the sale of the shares, after ... to be approximately $44 million.  Inhibitex has granted the underwriters ...
... April 7, 2011 Vystar® Corporation ... Rubber Latex (NRL), a patented, all-natural raw latex ... non-rubbers found in natural rubber latex, has appointed ... (Logo: http://photos.prnewswire.com/prnh/20100203/CL48049LOGO) Ms. Kearney is ...
Cached Medicine Technology:Inhibitex Prices $47 Million Public Offering 2Inhibitex Prices $47 Million Public Offering 3Vystar® Corporation Appoints Joanne Kearney as Vice President of Marketing 2Vystar® Corporation Appoints Joanne Kearney as Vice President of Marketing 3
... design and reduced dimensions provide ... control of IOL while grasping ... the optic. Curved shafts with ... curved. Smooth, flat, cross action ...
... implanting the haptic loop beneath the ... bag without wrist twisting. Angled 45 ... placed in the same vertical plane ... action handle with dull finish. Most ...
Smooth colibri tip used to grasp and subsequently retract the capsule during nucleus delivery. Serrated handle with polished finish....
Two rows of teeth on jaws provide a firm purchase on the nucleus fragment for removal. Flat handle with dull finish....
Medicine Products: